Tjalf Ziemssen1. Show Affiliations » 1. Max-Planck-Institute of Neurobiology, Department of Neuroimmunology, 82152 Martinsried, Germany.
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsAxons/pathologyBrain-Derived Neurotrophic Factor/metabolismDemyelinating Diseases/complicationsDemyelinating Diseases/drug therapyDemyelinating Diseases/pathologyDemyelinating Diseases/physiopathologyGlatiramer AcetateHistory, 20th CenturyHumansMultiple Sclerosis/drug therapyMultiple Sclerosis/pathologyMultiple Sclerosis/physiopathologyMultiple Sclerosis/prevention & controlNeurodegenerative Diseases/etiologyNeurodegenerative Diseases/physiopathologyNeurodegenerative Diseases/prevention & controlNeuroprotective Agents/historyNeuroprotective Agents/pharmacologyNeuroprotective Agents/therapeutic usePeptides/historyPeptides/pharmacologyPeptides/therapeutic use
Substances: See more » Brain-Derived Neurotrophic FactorNeuroprotective AgentsPeptidesGlatiramer Acetate
Year: 2004 PMID: 14977211 DOI: 10.1007/978-1-4419-8969-7_7
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622